Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| METTLER TOLEDO INTERNATIONAL INC/MTD · Entity 3168 | Director | February 17, 2026 | February 19, 2026 |
| STERIS plcSTE · Entity 3228 | Sr. Vice Pres., CFO | June 04, 2025 | June 06, 2025 |
| TELEFLEX INCTFX · Entity 3798 | Director | May 15, 2026 | May 20, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
METTLER TOLEDO INTERNATIONAL INC/
Report date February 17, 2026 · Filed February 19, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.01 per shareSEC Table I · non-derivative | Direct | 50 |
Reported balance
After 2026-02-17 transaction · row 1
1 source rowRow 1 · 2026-02-17 · Grant · Acquired 50 · Balance 50 |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1,353.24 · Expires 2036-02-17 | Direct | 130 |
Reported balance
After 2026-02-17 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-02-17 · Grant · Acquired 130 · Balance 130 F1: The options vest annually in two equal installments beginning on the first anniversary of the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: The options vest annually in two equal installments beginning on the first anniversary of the date of grant.
STERIS plc
Report date June 04, 2025 · Filed June 06, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 43,891 |
Reported balance
After 2025-06-04 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2025-06-04 · Tax withholding · Disposed 341 · Balance 43,891 F1: 341 shares were withheld from the 1,141 restricted shares that vested on June 4, 2025. These 341 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 1,141 ordinary shares were awarded to Mr. Tokich on June 4, 2024. These vested shares were valued at the NYSE closing market price on June 4, 2025. F2: As of June 4, 2025, 6,506 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 144 on October 1, 2025; 1,293 on June 1, 2026; 564 on June 2, 2026; 741 on June 3, 2026; 1,141 on June 4, 2026; 741 on June 3, 2027; 1,141 on June 4, 2027 and 741 on June 5, 2028. |
| Ordinary SharesSEC Table I · non-derivative | IndirectSee Footnote Below | 3,592 |
Reported balance
Holding disclosure · report date 2025-06-04 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 3,592 F3: Units representing 3,592 ordinary share equivalents are held on behalf of the Reporting Person under the STERIS Corporation 401(k) Plan as of June 2, 2025. |
Filing footnotes · ownership attribution and instrument terms
F1: 341 shares were withheld from the 1,141 restricted shares that vested on June 4, 2025. These 341 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 1,141 ordinary shares were awarded to Mr. Tokich on June 4, 2024. These vested shares were valued at the NYSE closing market price on June 4, 2025.
F2: As of June 4, 2025, 6,506 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 144 on October 1, 2025; 1,293 on June 1, 2026; 564 on June 2, 2026; 741 on June 3, 2026; 1,141 on June 4, 2026; 741 on June 3, 2027; 1,141 on June 4, 2027 and 741 on June 5, 2028.
F3: Units representing 3,592 ordinary share equivalents are held on behalf of the Reporting Person under the STERIS Corporation 401(k) Plan as of June 2, 2025.
TELEFLEX INC
Report date May 15, 2026 · Filed May 20, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,090 |
Reported balance
After 2026-05-15 transaction · row 1
1 source rowRow 1 · 2026-05-15 · Grant · Acquired 1,090 · Balance 1,090 F1: Restricted Stock Unit Award granted pursuant to the Teleflex Incorporated 2023 Stock Incentive Plan. Award vests 100% on the one-year anniversary of the grant date; provided, however, if the reporting person does not stand for re-election to the issuer's board of directors (the "Board") at the issuer's 2027 annual meeting of stockholders (the "2027 Annual Meeting"), the award will vest on the earlier of the one-year anniversary of the grant date and the date of the 2027 Annual Meeting, so long as such meeting is held at least 50 weeks after the issuer's 2026 annual meeting of stockholders (the "2026 Annual Meeting"). |
| Stock Option / (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $129.71 · Expires 2036-05-15 | Direct | 4,793 |
Reported balance
After 2026-05-15 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-05-15 · Grant · Acquired 4,793 · Balance 4,793 F2: Stock Option Award vests 100% on the one-year anniversary of the grant date; provided, however, if the reporting person does not stand for re-election to the Board at the 2027 Annual Meeting, the award will vest on the earlier of the one-year anniversary of the grant date and the date of the 2027 Annual Meeting, so long as such meeting is held at least 50 weeks after the 2026 Annual Meeting. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted Stock Unit Award granted pursuant to the Teleflex Incorporated 2023 Stock Incentive Plan. Award vests 100% on the one-year anniversary of the grant date; provided, however, if the reporting person does not stand for re-election to the issuer's board of directors (the "Board") at the issuer's 2027 annual meeting of stockholders (the "2027 Annual Meeting"), the award will vest on the earlier of the one-year anniversary of the grant date and the date of the 2027 Annual Meeting, so long as such meeting is held at least 50 weeks after the issuer's 2026 annual meeting of stockholders (the "2026 Annual Meeting").
F2: Stock Option Award vests 100% on the one-year anniversary of the grant date; provided, however, if the reporting person does not stand for re-election to the Board at the 2027 Annual Meeting, the award will vest on the earlier of the one-year anniversary of the grant date and the date of the 2027 Annual Meeting, so long as such meeting is held at least 50 weeks after the 2026 Annual Meeting.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
STERIS plc
Report date March 28, 2019 · Filed March 28, 2019
Section 16 reporting ended · disclosed 2019-03-28. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary Shares, 10 pence par valueSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 1
1 source rowRow 1 · 2019-03-28 · Disposition to issuer · Disposed 50,458 · Balance 0 F1: 25,940 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 7,000 on May 28, 2019; 4,000 on October 1, 2019; 4,700 on June 1, 2020; 6,000 on June 1, 2021; and 4,240 on May 31, 2022. F2: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"), cancelled pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), in an amount equal to the number of the reporting person's cancelled Old STERIS shares. The reporting person's STERIS shares will be subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS. |
| Ordinary Shares, 10 pence par valueSEC Table I · non-derivative | IndirectSee Footnote Below. | 0 |
Reported balance
After 2019-03-28 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2019-03-28 · Disposition to issuer · Disposed 3,406 · Balance 0 F2: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"), cancelled pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), in an amount equal to the number of the reporting person's cancelled Old STERIS shares. The reporting person's STERIS shares will be subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS. F3: Units representing 3,406 ordinary share equivalents are held on behalf of the Reporting Person under the STERIS Corporation 401(k) Plan as of March 27, 2019. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $45.34 · Expires 2023-05-31 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2019-03-28 · Disposition to issuer · Disposed 22,000 · Balance 0 F4: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 22,000 ordinary shares of STERIS for $45.34 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $53.52 · Expires 2024-05-30 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2019-03-28 · Disposition to issuer · Disposed 28,000 · Balance 0 F5: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 28,000 ordinary shares of STERIS for $53.52 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $67.98 · Expires 2025-08-10 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2019-03-28 · Disposition to issuer · Disposed 20,000 · Balance 0 F6: This option will become exercisable as follows: 5,000 on May 28, 2016; 5,000 on May 28, 2017; 5,000 on May 28, 2018 and 5,000 on May 28, 2019. This option was assumed by STERIS under the Scheme and converted to an option to purchase 20,000 ordinary shares of STERIS for $67.98 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $69.72 · Expires 2026-06-01 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2019-03-28 · Disposition to issuer · Disposed 30,000 · Balance 0 F7: This option becomes exercisable as follows: 7,500 on June 1, 2017; 7,500 on June 1, 2018; 7,500 on June 3, 2019 and 7,500 on June 1, 2020. This option was assumed by STERIS under the Scheme and converted to an option to purchase 30,000 ordinary shares of STERIS for $69.72 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $77.07 · Expires 2027-05-30 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2019-03-28 · Disposition to issuer · Disposed 32,000 · Balance 0 F8: This option becomes exercisable as follows: 8,000 on May 30, 2018; 8,000 on May 30, 2019; 8,000 on June 1, 2020 and 8,000 on June 1, 2021. This option was assumed by STERIS under the Scheme and converted to an option to purchase 32,000 ordinary shares of STERIS for $77.07 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $114.22 · Expires 2028-05-31 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2019-03-28 · Disposition to issuer · Disposed 46,664 · Balance 0 F9: This option becomes exercisable as follows: 11,666 on May 31, 2019; 11,666 on June 1, 2020; 11,666 on June 1, 2021 and 11,666 on May 31, 2022. This option was assumed by STERIS under the Scheme and converted to an option to purchase 46,664 ordinary shares of STERIS for $114.22 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
Filing footnotes · ownership attribution and instrument terms
F1: 25,940 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 7,000 on May 28, 2019; 4,000 on October 1, 2019; 4,700 on June 1, 2020; 6,000 on June 1, 2021; and 4,240 on May 31, 2022.
F2: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"), cancelled pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), in an amount equal to the number of the reporting person's cancelled Old STERIS shares. The reporting person's STERIS shares will be subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS.
F3: Units representing 3,406 ordinary share equivalents are held on behalf of the Reporting Person under the STERIS Corporation 401(k) Plan as of March 27, 2019.
F4: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 22,000 ordinary shares of STERIS for $45.34 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
F5: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 28,000 ordinary shares of STERIS for $53.52 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
F6: This option will become exercisable as follows: 5,000 on May 28, 2016; 5,000 on May 28, 2017; 5,000 on May 28, 2018 and 5,000 on May 28, 2019. This option was assumed by STERIS under the Scheme and converted to an option to purchase 20,000 ordinary shares of STERIS for $67.98 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
F7: This option becomes exercisable as follows: 7,500 on June 1, 2017; 7,500 on June 1, 2018; 7,500 on June 3, 2019 and 7,500 on June 1, 2020. This option was assumed by STERIS under the Scheme and converted to an option to purchase 30,000 ordinary shares of STERIS for $69.72 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
F8: This option becomes exercisable as follows: 8,000 on May 30, 2018; 8,000 on May 30, 2019; 8,000 on June 1, 2020 and 8,000 on June 1, 2021. This option was assumed by STERIS under the Scheme and converted to an option to purchase 32,000 ordinary shares of STERIS for $77.07 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
F9: This option becomes exercisable as follows: 11,666 on May 31, 2019; 11,666 on June 1, 2020; 11,666 on June 1, 2021 and 11,666 on May 31, 2022. This option was assumed by STERIS under the Scheme and converted to an option to purchase 46,664 ordinary shares of STERIS for $114.22 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 02, 2021 Filed Jun 3, 2021 20:45 UTC | STERIS plc STE · Entity 3228 | GrantEmployee Stock Option (right to buy) · Derivative | 36,296 | $0.00 Strike: $210.30 | $0.00 |
DisclosureSEC source: 0001209191-21-037704 · doc4.xml · derivative · entry 3 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,296 Underlying: Ordinary Shares · 36,296 shares Expires 2031-06-02 F4 · derivative.exercise_date: This option becomes exercisable as follows: 9,074 on June 2, 2022; 9,074 on June 2, 2023; 9,074 on June 3, 2024 and 9,074 on June 2, 2025. Read SEC document |
| June 02, 2021 Filed Jun 3, 2021 20:45 UTC | STERIS plc STE · Entity 3228 | GrantOrdinary Shares | 2,292 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-037704 · doc4.xml · nonDerivative · entry 1 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,868 F1 · shares: All 2,292 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,719 on June 3, 2024 and 573 on June 2, 2025. F2 · balance_after: 11,764 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 4,240 on May 31, 2022; 2,780 on May 31, 2023; 2,452 on June 3, 2024; 1,719 on June 3, 2024 and 573 on June 2, 2025. Read SEC document |
| June 01, 2021 Filed Jun 2, 2021 20:42 UTC | STERIS plc STE · Entity 3228 | Disposition to issuerOrdinary Shares | 1,946 | $188.43 | $366,684.78 |
DisclosureSEC source: 0001209191-21-037226 · doc4.xml · nonDerivative · entry 1 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,576 F1 · shares: 1,946 shares were withheld from the 6,000 restricted shares that vested on June 1, 2021. These 1,946 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 6,000 ordinary shares were awarded to Mr. Tokich on May 30, 2017. These vested shares were valued at the NYSE closing market price on June 1, 2021. F2 · balance_after: 9,472 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 4,240 on May 31, 2022; 2,780 on May 31, 2023 and 2,452 on June 3, 2024. Read SEC document |
| October 09, 2020 Filed Oct 13, 2020 20:34 UTC | STERIS plc STE · Entity 3228 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 27,920 | $0.00 Strike: $53.52 | $0.00 |
DisclosureSEC source: 0001209191-20-054638 · doc4.xml · derivative · entry 9 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 27,920 shares Expires 2024-05-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: This option to purchase 28,000 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 28,000 Old STERIS ordinary shares for $53.52 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. Read SEC document |
| October 09, 2020 Filed Oct 13, 2020 20:34 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 6,243 | $189.00 | $1,179,927.00 |
DisclosureSEC source: 0001209191-20-054638 · doc4.xml · nonDerivative · entry 6 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,522 F7 · shares: This exercise of stock options and sale of a total of 6,243 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on June 2, 2020. F8 · price: Price reflects a weighted average sale price for multiple transactions ranging from $188.6950 to $189.2850 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F1 · balance_after: 15,472 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 6,000 on June 1, 2021; 4,240 on May 31, 2022; 2,780 on May 31, 2023 and 2,452 on June 3, 2024. Read SEC document |
| October 09, 2020 Filed Oct 13, 2020 20:34 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 15,677 | $188.24 | $2,951,038.48 |
DisclosureSEC source: 0001209191-20-054638 · doc4.xml · nonDerivative · entry 5 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,765 F5 · shares: This exercise of stock options and sale of a total of 15,677 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on June 2, 2020. F6 · price: Price reflects a weighted average sale price for multiple transactions ranging from $187.6950 to $188.68 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F1 · balance_after: 15,472 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 6,000 on June 1, 2021; 4,240 on May 31, 2022; 2,780 on May 31, 2023 and 2,452 on June 3, 2024. Read SEC document |
| October 09, 2020 Filed Oct 13, 2020 20:34 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 6,000 | $187.17 | $1,123,020.00 |
DisclosureSEC source: 0001209191-20-054638 · doc4.xml · nonDerivative · entry 4 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,442 F3 · shares: This exercise of stock options and sale of a total of 6,000 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on June 2, 2020. F4 · price: Price reflects a weighted average sale price for multiple transactions ranging from $186.61 to $187.59 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F1 · balance_after: 15,472 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 6,000 on June 1, 2021; 4,240 on May 31, 2022; 2,780 on May 31, 2023 and 2,452 on June 3, 2024. Read SEC document |
| October 09, 2020 Filed Oct 13, 2020 20:34 UTC | STERIS plc STE · Entity 3228 | Exercise / conversionOrdinary Shares | 27,920 | $53.52 | $1,494,278.40 |
DisclosureSEC source: 0001209191-20-054638 · doc4.xml · nonDerivative · entry 3 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,442 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: 15,472 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 6,000 on June 1, 2021; 4,240 on May 31, 2022; 2,780 on May 31, 2023 and 2,452 on June 3, 2024. Read SEC document |
| October 08, 2020 Filed Oct 13, 2020 20:34 UTC | STERIS plc STE · Entity 3228 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 80 | $0.00 Strike: $53.52 | $0.00 |
DisclosureSEC source: 0001209191-20-054638 · doc4.xml · derivative · entry 8 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,920 Underlying: Ordinary Shares · 80 shares Expires 2024-05-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: This option to purchase 28,000 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 28,000 Old STERIS ordinary shares for $53.52 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. Read SEC document |
| October 08, 2020 Filed Oct 13, 2020 20:34 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 80 | $187.00 | $14,960.00 |
DisclosureSEC source: 0001209191-20-054638 · doc4.xml · nonDerivative · entry 2 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,522 F2 · shares: This exercise of stock options and sale of a total of 80 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on June 2, 2020. F1 · balance_after: 15,472 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 6,000 on June 1, 2021; 4,240 on May 31, 2022; 2,780 on May 31, 2023 and 2,452 on June 3, 2024. Read SEC document |
| October 08, 2020 Filed Oct 13, 2020 20:34 UTC | STERIS plc STE · Entity 3228 | Exercise / conversionOrdinary Shares | 80 | $53.52 | $4,281.60 |
DisclosureSEC source: 0001209191-20-054638 · doc4.xml · nonDerivative · entry 1 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,602 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: 15,472 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 6,000 on June 1, 2021; 4,240 on May 31, 2022; 2,780 on May 31, 2023 and 2,452 on June 3, 2024. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 20:34 UTC | STERIS plc STE · Entity 3228 | GrantEmployee Stock Option (right to buy) · Derivative | 44,472 | $0.00 Strike: $182.22 | $0.00 |
DisclosureSEC source: 0001209191-20-034046 · doc4.xml · derivative · entry 4 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,472 Underlying: Ordinary Shares · 44,472 shares Expires 2030-06-01 F5 · derivative.exercise_date: This option becomes exercisable as follows: 11,118 on June 1, 2021; 11,118 on June 1, 2022; 11,118 on June 1, 2023 and 11,118 on June 3, 2024. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 20:34 UTC | STERIS plc STE · Entity 3228 | Disposition to issuerOrdinary Shares | 1,454 | $165.65 | $240,855.10 |
DisclosureSEC source: 0001209191-20-034046 · doc4.xml · nonDerivative · entry 2 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,522 F2 · shares: 1,454 shares were withheld from the 4,700 restricted shares that vested on June 1, 2020. These 1,454 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 4,700 ordinary shares were awarded to Mr. Tokich on June 1, 2016. These vested shares were valued at the NYSE closing market price on June 1, 2020. F3 · balance_after: 15,472 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 6,000 on June 1, 2021; 4,240 on May 31, 2022; 2,780 on May 31, 2023 and 2,452 on June 3, 2024. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 20:34 UTC | STERIS plc STE · Entity 3228 | GrantOrdinary Shares | 2,452 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-034046 · doc4.xml · nonDerivative · entry 1 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,976 F1 · shares: All 2,452 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse on June 3, 2024. Read SEC document |
| May 28, 2020 Filed Jun 1, 2020 20:33 UTC | STERIS plc STE · Entity 3228 | Disposition to issuerOrdinary Shares | 4,000 | $162.70 | $650,800.00 |
DisclosureSEC source: 0001209191-20-033197 · doc4.xml · nonDerivative · entry 1 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,524 F1 · balance_after: 17,720 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 4,700 on June 1, 2020; 6,000 on June 1, 2021; 4,240 on May 31, 2022 and 2,780 on May 31, 2023. Read SEC document |
| October 01, 2019 Filed Oct 2, 2019 20:39 UTC | STERIS plc STE · Entity 3228 | Tax withholdingOrdinary Shares | 2,041 | $140.62 | $287,005.42 |
DisclosureSEC source: 0001209191-19-051740 · doc4.xml · nonDerivative · entry 1 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,524 F1 · balance_after: 17,720 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 4,700 on June 1, 2020; 6,000 on June 1, 2021; 4,240 on May 31, 2022 and 2,780 on May 31, 2023. Read SEC document |
| June 21, 2019 Filed Jun 21, 2019 20:29 UTC | STERIS plc STE · Entity 3228 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 19,986 | $0.00 Strike: $45.34 | $0.00 |
DisclosureSEC source: 0001209191-19-038469 · doc4.xml · derivative · entry 8 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 19,986 shares Expires 2023-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option to purchase 22,000 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 22,000 Old STERIS ordinary shares for $45.34 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. Read SEC document |
| June 21, 2019 Filed Jun 21, 2019 20:29 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 6,290 | $144.07 | $906,200.30 |
DisclosureSEC source: 0001209191-19-038469 · doc4.xml · nonDerivative · entry 5 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,565 F4 · shares: This Exercise and sale of a total of 19,986 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on May 22, 2019. F6 · price: Price reflects a weighted average sale price for multiple transactions ranging from $143.77 to $144.52 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F7 · balance_after: 21,720 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 4,000 on October 1, 2019; 4,700 on June 1, 2020; 6,000 on June 1, 2021; 4,240 on May 31, 2022 and 2,780 on May 31, 2023. Read SEC document |
| June 21, 2019 Filed Jun 21, 2019 20:29 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 13,696 | $143.17 | $1,960,856.32 |
DisclosureSEC source: 0001209191-19-038469 · doc4.xml · nonDerivative · entry 4 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,855 F4 · shares: This Exercise and sale of a total of 19,986 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on May 22, 2019. F5 · price: Price reflects a weighted average sale price for multiple transactions ranging from $142.75 to $143.74 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 21, 2019 Filed Jun 21, 2019 20:29 UTC | STERIS plc STE · Entity 3228 | Exercise / conversionOrdinary Shares | 19,986 | $45.34 | $906,165.24 |
DisclosureSEC source: 0001209191-19-038469 · doc4.xml · nonDerivative · entry 3 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,551 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: This option to purchase 22,000 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 22,000 Old STERIS ordinary shares for $45.34 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. F4 · shares: This Exercise and sale of a total of 19,986 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on May 22, 2019. Read SEC document |
| June 20, 2019 Filed Jun 21, 2019 20:29 UTC | STERIS plc STE · Entity 3228 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,014 | $0.00 Strike: $45.34 | $0.00 |
DisclosureSEC source: 0001209191-19-038469 · doc4.xml · derivative · entry 7 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,986 Underlying: Ordinary Shares · 22,000 shares Expires 2023-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option to purchase 22,000 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 22,000 Old STERIS ordinary shares for $45.34 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. Read SEC document |
| June 20, 2019 Filed Jun 21, 2019 20:29 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Sahres | 2,014 | $146.12 | $294,285.68 |
DisclosureSEC source: 0001209191-19-038469 · doc4.xml · nonDerivative · entry 2 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,565 F1 · shares: This Exercise and sale of a total of 2,014 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on May 22, 2019. F3 · price: Price reflects a weighted average sale price for multiple transactions ranging from $146.00 to $146.62 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 20, 2019 Filed Jun 21, 2019 20:29 UTC | STERIS plc STE · Entity 3228 | Exercise / conversionOrdinary Shares | 2,014 | $45.34 | $91,314.76 |
DisclosureSEC source: 0001209191-19-038469 · doc4.xml · nonDerivative · entry 1 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,579 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This Exercise and sale of a total of 2,014 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on May 22, 2019. F2 · shares: This option to purchase 22,000 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 22,000 Old STERIS ordinary shares for $45.34 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. Read SEC document |
| May 31, 2019 Filed Jun 3, 2019 20:43 UTC | STERIS plc STE · Entity 3228 | GrantEmployee Stock Option (right to buy) · Derivative | 48,116 | $0.00 Strike: $147.05 | $0.00 |
DisclosureSEC source: 0001209191-19-033952 · doc4.xml · derivative · entry 3 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,116 Underlying: Ordinary Shares · 48,116 shares Expires 2029-05-31 F4 · derivative.exercise_date: This option becomes exercisable as follows: 12,029 on June 1, 2020; 12,029 on June 1, 2021; 12,029 on May 31, 2022 and 12,029 on May 31, 2023. Read SEC document |
| May 31, 2019 Filed Jun 3, 2019 20:43 UTC | STERIS plc STE · Entity 3228 | GrantOrdinary Shares | 2,780 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-033952 · doc4.xml · nonDerivative · entry 1 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,565 F1 · shares: All 2,780 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 2,780 on May 31, 2023. F2 · balance_after: 21,720 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 4,000 on October 1, 2019; 4,700 on June 1, 2020; 6,000 on June 1, 2021; 4,240 on May 31, 2022 and 2,780 on May 31, 2023. Read SEC document |
| May 28, 2019 Filed May 30, 2019 20:39 UTC | STERIS plc STE · Entity 3228 | Tax withholdingOrdinary Shares | 2,673 | $133.92 | $357,968.16 |
DisclosureSEC source: 0001209191-19-033445 · doc4.xml · nonDerivative · entry 1 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,785 F1 · shares: 2,673 shares were withheld from the 7,000 restricted shares that vested on May 28, 2019. These 2,673 ordinary shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 7,000 ordinary shares were awarded to Mr. Tokich on August 10, 2015. These vested shares were valued at the NYSE closing market price on May 28, 2019. F2 · balance_after: 18,940 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 4,000 on October 1, 2019; 4,700 on June 1, 2020; 6,000 on June 1, 2021; and 4,240 on May 31, 2022. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:46 UTC | STERIS plc STE · Entity 3228 | GrantEmployee Stock Option (right to buy) · Derivative | 46,664 | Not disclosed Strike: $114.22 | Not disclosed |
DisclosureSEC source: 0001209191-19-021612 · doc4.xml · derivative · entry 8 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,664 Underlying: Ordinary Shares · 46,664 shares Expires 2028-05-31 F9 · price: This option becomes exercisable as follows: 11,666 on May 31, 2019; 11,666 on June 1, 2020; 11,666 on June 1, 2021 and 11,666 on May 31, 2022. This option was received under the Scheme in exchange for an option to purchase 46,664 STERIS ordinary shares for $114.22 per share, subject to the same terms and conditions as the original Old STERIS stock option. F9 · derivative.exercise_date: This option becomes exercisable as follows: 11,666 on May 31, 2019; 11,666 on June 1, 2020; 11,666 on June 1, 2021 and 11,666 on May 31, 2022. This option was received under the Scheme in exchange for an option to purchase 46,664 STERIS ordinary shares for $114.22 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:46 UTC | STERIS plc STE · Entity 3228 | GrantEmployee Stock Option (right to buy) · Derivative | 32,000 | Not disclosed Strike: $77.07 | Not disclosed |
DisclosureSEC source: 0001209191-19-021612 · doc4.xml · derivative · entry 7 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,000 Underlying: Ordinary Shares · 32,000 shares Expires 2027-05-30 F8 · price: This option becomes exercisable as follows: 8,000 on May 30, 2018; 8,000 on May 30, 2019; 8,000 on June 1, 2020 and 8,000 on June 1, 2021. This option was received under the Scheme in exchange for an option to purchase 32,000 STERIS ordinary shares for $77.07 per share, subject to the same terms and conditions as the original Old STERIS stock option. F8 · derivative.exercise_date: This option becomes exercisable as follows: 8,000 on May 30, 2018; 8,000 on May 30, 2019; 8,000 on June 1, 2020 and 8,000 on June 1, 2021. This option was received under the Scheme in exchange for an option to purchase 32,000 STERIS ordinary shares for $77.07 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:46 UTC | STERIS plc STE · Entity 3228 | GrantEmployee Stock Option (right to buy) · Derivative | 30,000 | Not disclosed Strike: $69.72 | Not disclosed |
DisclosureSEC source: 0001209191-19-021612 · doc4.xml · derivative · entry 6 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Ordinary Shares · 30,000 shares Expires 2026-06-01 F7 · price: This option becomes exercisable as follows: 7,500 on June 1, 2017; 7,500 on June 1, 2018; 7,500 on June 3, 2019 and 7,500 on June 1, 2020. This option was received under the Scheme in exchange for an option to purchase 30,000 STERIS ordinary shares for $69.72 per share, subject to the same terms and conditions as the original Old STERIS stock option. F7 · derivative.exercise_date: This option becomes exercisable as follows: 7,500 on June 1, 2017; 7,500 on June 1, 2018; 7,500 on June 3, 2019 and 7,500 on June 1, 2020. This option was received under the Scheme in exchange for an option to purchase 30,000 STERIS ordinary shares for $69.72 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:46 UTC | STERIS plc STE · Entity 3228 | GrantEmployee Stock Option (right to buy) · Derivative | 20,000 | Not disclosed Strike: $67.98 | Not disclosed |
DisclosureSEC source: 0001209191-19-021612 · doc4.xml · derivative · entry 5 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Ordinary Shares · 20,000 shares Expires 2025-08-10 F6 · price: This option becomes exercisable as follows: 5,000 on May 28, 2016; 5,000 on May 28, 2017; 5,000 on May 28, 2018 and 5,000 on May 28, 2019. This option was received under the Scheme in exchange for an option to purchase 20,000 STERIS ordinary shares for $67.98 per share, subject to the same terms and conditions as the original Old STERIS stock option. F6 · derivative.exercise_date: This option becomes exercisable as follows: 5,000 on May 28, 2016; 5,000 on May 28, 2017; 5,000 on May 28, 2018 and 5,000 on May 28, 2019. This option was received under the Scheme in exchange for an option to purchase 20,000 STERIS ordinary shares for $67.98 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:46 UTC | STERIS plc STE · Entity 3228 | GrantEmployee Stock Option (right to buy) · Derivative | 28,000 | Not disclosed Strike: $53.52 | Not disclosed |
DisclosureSEC source: 0001209191-19-021612 · doc4.xml · derivative · entry 4 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,000 Underlying: Ordinary Shares · 28,000 shares Expires 2024-05-30 F5 · price: This option to purchase 28,000 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 28,000 Old STERIS ordinary shares for $53.52 per share, subject to the same terms and conditions as the original Old STERIS stock option F5 · derivative.exercise_date: This option to purchase 28,000 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 28,000 Old STERIS ordinary shares for $53.52 per share, subject to the same terms and conditions as the original Old STERIS stock option Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:46 UTC | STERIS plc STE · Entity 3228 | GrantEmployee Stock Option (right to buy) · Derivative | 22,000 | Not disclosed Strike: $45.34 | Not disclosed |
DisclosureSEC source: 0001209191-19-021612 · doc4.xml · derivative · entry 3 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,000 Underlying: Ordinary Shares · 22,000 shares Expires 2023-05-31 F4 · price: This option to purchase 22,000 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 22,000 Old STERIS ordinary shares for $45.34 per share, subject to the same terms and conditions as the original Old STERIS stock option. F4 · derivative.exercise_date: This option to purchase 22,000 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 22,000 Old STERIS ordinary shares for $45.34 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:46 UTC | STERIS plc STE · Entity 3228 | GrantOrdinary Shares | 3,406 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-021612 · doc4.xml · nonDerivative · entry 2 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Below Disclosed balance after: 3,406 F2 · price: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS") received by the reporting person pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received shares of STERIS in an amount equal to the number of the reporting person's cancelled shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"). The reporting person's STERIS shares are subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS. F3 · ownership.nature: Units representing 3,406 ordinary share equivalents are held on behalf of the Reporting Person under the STERIS Corporation 401(k) Plan as of March 27, 2019. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:46 UTC | STERIS plc STE · Entity 3228 | GrantOrdinary Shares | 50,458 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-021612 · doc4.xml · nonDerivative · entry 1 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,458 F1 · shares: 25,940 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 7,000 on May 28, 2019; 4,000 on October 1, 2019; 4,700 on June 1, 2020; 6,000 on June 1, 2021; and 4,240 on May 31, 2022. F2 · price: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS") received by the reporting person pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received shares of STERIS in an amount equal to the number of the reporting person's cancelled shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"). The reporting person's STERIS shares are subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS. F1 · balance_after: 25,940 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 7,000 on May 28, 2019; 4,000 on October 1, 2019; 4,700 on June 1, 2020; 6,000 on June 1, 2021; and 4,240 on May 31, 2022. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 14:16 UTC | STERIS plc STE · Entity 158792 | Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 46,664 | Not disclosed Strike: $114.22 | Not disclosed |
DisclosureSEC source: 0001209191-19-021569 · doc4.xml · derivative · entry 8 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 46,664 shares Expires 2028-05-31 F9 · price: This option becomes exercisable as follows: 11,666 on May 31, 2019; 11,666 on June 1, 2020; 11,666 on June 1, 2021 and 11,666 on May 31, 2022. This option was assumed by STERIS under the Scheme and converted to an option to purchase 46,664 ordinary shares of STERIS for $114.22 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. F9 · derivative.exercise_date: This option becomes exercisable as follows: 11,666 on May 31, 2019; 11,666 on June 1, 2020; 11,666 on June 1, 2021 and 11,666 on May 31, 2022. This option was assumed by STERIS under the Scheme and converted to an option to purchase 46,664 ordinary shares of STERIS for $114.22 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 14:16 UTC | STERIS plc STE · Entity 158792 | Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 32,000 | Not disclosed Strike: $77.07 | Not disclosed |
DisclosureSEC source: 0001209191-19-021569 · doc4.xml · derivative · entry 7 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 32,000 shares Expires 2027-05-30 F8 · price: This option becomes exercisable as follows: 8,000 on May 30, 2018; 8,000 on May 30, 2019; 8,000 on June 1, 2020 and 8,000 on June 1, 2021. This option was assumed by STERIS under the Scheme and converted to an option to purchase 32,000 ordinary shares of STERIS for $77.07 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. F8 · derivative.exercise_date: This option becomes exercisable as follows: 8,000 on May 30, 2018; 8,000 on May 30, 2019; 8,000 on June 1, 2020 and 8,000 on June 1, 2021. This option was assumed by STERIS under the Scheme and converted to an option to purchase 32,000 ordinary shares of STERIS for $77.07 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 14:16 UTC | STERIS plc STE · Entity 158792 | Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 30,000 | Not disclosed Strike: $69.72 | Not disclosed |
DisclosureSEC source: 0001209191-19-021569 · doc4.xml · derivative · entry 6 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 30,000 shares Expires 2026-06-01 F7 · price: This option becomes exercisable as follows: 7,500 on June 1, 2017; 7,500 on June 1, 2018; 7,500 on June 3, 2019 and 7,500 on June 1, 2020. This option was assumed by STERIS under the Scheme and converted to an option to purchase 30,000 ordinary shares of STERIS for $69.72 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. F7 · derivative.exercise_date: This option becomes exercisable as follows: 7,500 on June 1, 2017; 7,500 on June 1, 2018; 7,500 on June 3, 2019 and 7,500 on June 1, 2020. This option was assumed by STERIS under the Scheme and converted to an option to purchase 30,000 ordinary shares of STERIS for $69.72 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 14:16 UTC | STERIS plc STE · Entity 158792 | Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 20,000 | Not disclosed Strike: $67.98 | Not disclosed |
DisclosureSEC source: 0001209191-19-021569 · doc4.xml · derivative · entry 5 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 20,000 shares Expires 2025-08-10 F6 · price: This option will become exercisable as follows: 5,000 on May 28, 2016; 5,000 on May 28, 2017; 5,000 on May 28, 2018 and 5,000 on May 28, 2019. This option was assumed by STERIS under the Scheme and converted to an option to purchase 20,000 ordinary shares of STERIS for $67.98 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. F6 · derivative.exercise_date: This option will become exercisable as follows: 5,000 on May 28, 2016; 5,000 on May 28, 2017; 5,000 on May 28, 2018 and 5,000 on May 28, 2019. This option was assumed by STERIS under the Scheme and converted to an option to purchase 20,000 ordinary shares of STERIS for $67.98 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 14:16 UTC | STERIS plc STE · Entity 158792 | Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 28,000 | Not disclosed Strike: $53.52 | Not disclosed |
DisclosureSEC source: 0001209191-19-021569 · doc4.xml · derivative · entry 4 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 28,000 shares Expires 2024-05-30 F5 · price: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 28,000 ordinary shares of STERIS for $53.52 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. F5 · derivative.exercise_date: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 28,000 ordinary shares of STERIS for $53.52 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 14:16 UTC | STERIS plc STE · Entity 158792 | Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 22,000 | Not disclosed Strike: $45.34 | Not disclosed |
DisclosureSEC source: 0001209191-19-021569 · doc4.xml · derivative · entry 3 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 22,000 shares Expires 2023-05-31 F4 · price: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 22,000 ordinary shares of STERIS for $45.34 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. F4 · derivative.exercise_date: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 22,000 ordinary shares of STERIS for $45.34 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 14:16 UTC | STERIS plc STE · Entity 158792 | Disposition to issuerOrdinary Shares, 10 pence par value | 3,406 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-021569 · doc4.xml · nonDerivative · entry 2 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Below. Disclosed balance after: 0 F2 · price: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"), cancelled pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), in an amount equal to the number of the reporting person's cancelled Old STERIS shares. The reporting person's STERIS shares will be subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS. F3 · ownership.nature: Units representing 3,406 ordinary share equivalents are held on behalf of the Reporting Person under the STERIS Corporation 401(k) Plan as of March 27, 2019. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 14:16 UTC | STERIS plc STE · Entity 158792 | Disposition to issuerOrdinary Shares, 10 pence par value | 50,458 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-021569 · doc4.xml · nonDerivative · entry 1 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: 25,940 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 7,000 on May 28, 2019; 4,000 on October 1, 2019; 4,700 on June 1, 2020; 6,000 on June 1, 2021; and 4,240 on May 31, 2022. F2 · price: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"), cancelled pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), in an amount equal to the number of the reporting person's cancelled Old STERIS shares. The reporting person's STERIS shares will be subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS. Read SEC document |
| November 07, 2018 Filed Nov 8, 2018 21:32 UTC | STERIS plc STE · Entity 158792 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $29.94 | $0.00 |
DisclosureSEC source: 0001209191-18-057749 · doc4.xml · derivative · entry 7 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 20,000 shares Expires 2022-05-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option to purchase 20,000 STERIS plc ordinary shares, which is fully vested, was received in the Merger in exchange for an option to purchase 20,000 STERIS Corporation common shares for $29.94 per share, subject to the same terms and conditions as the original STERIS stock option. Read SEC document |
| November 07, 2018 Filed Nov 8, 2018 21:32 UTC | STERIS plc STE · Entity 158792 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 14,500 | $0.00 Strike: $36.09 | $0.00 |
DisclosureSEC source: 0001209191-18-057749 · doc4.xml · derivative · entry 6 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 14,500 shares Expires 2021-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option to purchase 14,500 STERIS plc ordinary shares, which is fully vested, was received in the Merger in exchange for an option to purchase 14,500 STERIS Corporation common shares for $36.09 per share, subject to the same terms and conditions as the original STERIS stock option. Read SEC document |
| November 07, 2018 Filed Nov 8, 2018 21:32 UTC | STERIS plc STE · Entity 158792 | SaleOrdinary Shares, 10 pence par value | 20,000 | $120.00 | $2,400,000.00 |
DisclosureSEC source: 0001209191-18-057749 · doc4.xml · nonDerivative · entry 4 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,458 F1 · shares: This exercise and sale of a total of 34,500 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on June 4, 2018. F2 · balance_after: 25,940 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 7,000 on May 28, 2019; 4,000 on October 1, 2019; 4,700 on June 1, 2020; 6,000 on June 1, 2021; and 4,240 on May 31, 2022. Read SEC document |
| November 07, 2018 Filed Nov 8, 2018 21:32 UTC | STERIS plc STE · Entity 158792 | Exercise / conversionOrdinary Shares, 10 pence par value | 20,000 | $29.94 | $598,800.00 |
DisclosureSEC source: 0001209191-18-057749 · doc4.xml · nonDerivative · entry 3 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,458 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This exercise and sale of a total of 34,500 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on June 4, 2018. Read SEC document |
| November 07, 2018 Filed Nov 8, 2018 21:32 UTC | STERIS plc STE · Entity 158792 | SaleOrdinary Shares, 10 pence par value | 14,500 | $118.00 | $1,711,000.00 |
DisclosureSEC source: 0001209191-18-057749 · doc4.xml · nonDerivative · entry 2 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,458 F1 · shares: This exercise and sale of a total of 34,500 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on June 4, 2018. Read SEC document |
| November 07, 2018 Filed Nov 8, 2018 21:32 UTC | STERIS plc STE · Entity 158792 | Exercise / conversionOrdinary Shares, 10 pence par value | 14,500 | $36.09 | $523,305.00 |
DisclosureSEC source: 0001209191-18-057749 · doc4.xml · nonDerivative · entry 1 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,958 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This exercise and sale of a total of 34,500 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on June 4, 2018. Read SEC document |
| May 31, 2018 Filed Jun 1, 2018 20:55 UTC | STERIS plc STE · Entity 158792 | GrantEmployee Stock Option (right to buy) · Derivative | 46,664 | $0.00 Strike: $114.22 | $0.00 |
DisclosureSEC source: 0001209191-18-034745 · doc4.xml · derivative · entry 4 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,664 Underlying: Ordinary Shares · 46,664 shares Expires 2028-05-31 F5 · derivative.exercise_date: This option becomes exercisable as follows: 11,666 on May 31, 2019; 11,666 on June 1, 2020; 11,666 on June 1, 2021 and 11,666 on May 31, 2022. Read SEC document |
| May 31, 2018 Filed Jun 1, 2018 20:55 UTC | STERIS plc STE · Entity 158792 | GrantOrdinary Shares, 10 pence par value | 4,240 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-034745 · doc4.xml · nonDerivative · entry 2 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,458 F2 · shares: All 4,240 of these Common Shares are restricted. The restrictions on these Common Shares lapse as follows: 4,240 on May 31, 2022. F3 · balance_after: 25,940 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 7,000 on May 28, 2019; 4,000 on October 1, 2019; 4,700 on June 1, 2020; 6,000 on June 1, 2021; and 4,240 on May 31, 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.